These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14257)

  • 1. Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
    Rastogi RB; Lapierre YD; Singhal RL
    J Psychiatr Res; 1977; 13(2):65-75. PubMed ID: 14257
    [No Abstract]   [Full Text] [Related]  

  • 2. Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines.
    Rastogi RB; Lapierre YD; Singhal RL
    Prog Neuropsychopharmacol; 1978; 2(1):43-54. PubMed ID: 31644
    [No Abstract]   [Full Text] [Related]  

  • 3. Central effects of acetylcholine.
    Herman ZS; Kmieciak-Kolada K; Slominska-Zurek J; Szkilnik R
    Psychopharmacologia; 1972; 27(3):223-32. PubMed ID: 4642461
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional catecholamine content in the rat brain: sex differences and correlation with motor activity.
    Gordon JH; Shellenberger K
    Neuropharmacology; 1974 Feb; 13(2):129-37. PubMed ID: 4822599
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

  • 6. The dynamics of dopamine metabolism in various regions of rat brain.
    Karoum F; Neff NH; Wyatt RJ
    Eur J Pharmacol; 1977 Aug; 44(4):311-8. PubMed ID: 891608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional distribution of catecholamines in rat brain after L-3-O-methyldopa and L-dopa.
    Bartholini G; Lloyd KG; Pletscher A
    Life Sci; 1974 Jan; 14(2):323-8. PubMed ID: 4813592
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.
    Agarwal RA; Lapierre YD; Rastogi RB; Singhal RL
    Br J Pharmacol; 1977 May; 60(1):3-9. PubMed ID: 18243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short and long-lasting diabetes mellitus on mouse brain monoamines.
    Chen CC; Yang JC
    Brain Res; 1991 Jun; 552(1):175-9. PubMed ID: 1913176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and biochemical effects of 6-hydroxydopa in rats.
    Kmieciak-Kolada K; Herman ZS; Slomińska-Zurek J
    Psychopharmacologia; 1974 Mar; 35(4):341-52. PubMed ID: 4857558
    [No Abstract]   [Full Text] [Related]  

  • 11. Central aminergic mechanisms associated with the clonidine withdrawal syndrome.
    Lewis SJ; Fennessy MR; Taylor DA
    Clin Exp Pharmacol Physiol; 1981; 8(5):489-95. PubMed ID: 7198946
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of rubidium and cesium on central catecholamines and locomotor behavior in rats.
    Rastogi RB; Singhal RL; Lapierre YD
    J Neurochem; 1980 Jun; 34(6):1764-7. PubMed ID: 7381502
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat.
    Narotzky R; Griffith D; Stahl S; Bondareff W; Zeller EA
    Exp Neurol; 1973 Feb; 38(2):218-30. PubMed ID: 4690179
    [No Abstract]   [Full Text] [Related]  

  • 14. Some persistent effects of the pre- and neonatal administration of psychotropic drugs on noradrenaline metabolism in discrete areas of rat brain.
    Tonge SR; Leonard BE
    Br J Pharmacol; 1973 Jun; 48(2):364P-365P. PubMed ID: 4739053
    [No Abstract]   [Full Text] [Related]  

  • 15. Central action of 11-(3-dimethylaminopropylidene)-6,11-dihydro-dibenzo-(b,e)oxepine hydrocholoride (doxepine).
    Zieliński M; Janiec W; Herman ZS
    Pol J Pharmacol Pharm; 1973; 25(1):17-22. PubMed ID: 4149574
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine levels and monoamine oxidase activity in different regions of rat brain as a function of age.
    Bhaskaran D; Radha E
    Mech Ageing Dev; 1983 Oct; 23(2):151-60. PubMed ID: 6140331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates.
    Snyder SH; Coyle JT
    J Pharmacol Exp Ther; 1969 Jan; 165(1):78-86. PubMed ID: 5782836
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions.
    Knott PJ; Curzon G
    J Neurochem; 1974 Jun; 22(6):1065-71. PubMed ID: 4851651
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent abnormalities in central nervous system function (long-term tolerance) after brief ethanol administration.
    Gitlow SE; Dziedzic SW; Dziedzic LB
    Drug Alcohol Depend; 1977; 2(5-6):453-68. PubMed ID: 199408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.